{"id":3902,"date":"2013-10-28T16:01:41","date_gmt":"2013-10-28T15:01:41","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=3902"},"modified":"2013-10-28T16:01:41","modified_gmt":"2013-10-28T15:01:41","slug":"lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/","title":{"rendered":"L&#8217;actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignleft  wp-image-3908\" alt=\"Dibujo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg\" width=\"231\" height=\"303\" \/><\/a>Aqu\u00ed trobareu el n\u00famero de la<a href=\"http:\/\/www.cofb.org\/c\/document_library\/get_file?p_l_id=10132&amp;folderId=252210&amp;name=DLFE-14601.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\">\u00a0<\/span><span style=\"text-decoration: underline;\"><strong>revista cient\u00edfica del Col\u00b7legi\u00a0<em>Circular Farmac\u00e8utica,\u00a0<\/em>corresponent al tercer trimestre de 2013<\/strong><\/span><\/a>. Els temes tractats s\u00f3n, entre d\u2019altres:<\/p>\n<p><strong>Farmacoter\u00e0pia<br \/>\n<\/strong>&#8211; Actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica<br \/>\n&#8211; Gesti\u00f3 terap\u00e8utica i\u00a0la infecci\u00f3 f\u00fangica invasiva en el pacient adult<br \/>\n&#8211;\u00a0Estudi de l\u2019adequaci\u00f3 de la profilaxi quir\u00fargica del tromboembolisme ven\u00f3s<\/p>\n<p><strong>Casos cl\u00ednics<\/strong><br \/>\n&#8211;\u00a0Infecci\u00f3 pulmonar acompanyada d\u2019hemoptisi<br \/>\n&#8211;\u00a0Espondilitis per escherichia coli productora de betalactamases d\u2019ampli espectre<\/p>\n<p><strong>Alimentaci\u00f3 i nutrici\u00f3<\/strong><br \/>\n&#8211;\u00a0Est\u00e8via rebaudiana bertoni, l\u2019edulcorant acal\u00f2ric<\/p>\n<p>Veure<span style=\"text-decoration: underline;\">\u00a0<a href=\"http:\/\/www.cofb.org\/web\/guest\/circular-farmaceutica\" target=\"_blank\" rel=\"noopener\">n\u00fameros anteriors de<em>\u00a0Circular Farmac\u00e8utica<\/em><\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aqu\u00ed trobareu el n\u00famero de la\u00a0revista cient\u00edfica del Col\u00b7legi\u00a0Circular Farmac\u00e8utica,\u00a0corresponent al tercer trimestre de 2013. Els temes tractats s\u00f3n, entre d\u2019altres: Farmacoter\u00e0pia &#8211; Actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica &#8211; Gesti\u00f3 terap\u00e8utica i\u00a0la infecci\u00f3 f\u00fangica invasiva en el pacient adult &#8211;\u00a0Estudi de l\u2019adequaci\u00f3 de la profilaxi quir\u00fargica del tromboembolisme ven\u00f3s [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[32],"tags":[2149],"class_list":["post-3902","post","type-post","status-publish","format-standard","hentry","category-noticies-farmacia","tag-publicacions"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L&#039;actualitzaci\u00f3 del tractament de l&#039;hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;actualitzaci\u00f3 del tractament de l&#039;hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Aqu\u00ed trobareu el n\u00famero de la\u00a0revista cient\u00edfica del Col\u00b7legi\u00a0Circular Farmac\u00e8utica,\u00a0corresponent al tercer trimestre de 2013. Els temes tractats s\u00f3n, entre d\u2019altres: Farmacoter\u00e0pia &#8211; Actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica &#8211; Gesti\u00f3 terap\u00e8utica i\u00a0la infecci\u00f3 f\u00fangica invasiva en el pacient adult &#8211;\u00a0Estudi de l\u2019adequaci\u00f3 de la profilaxi quir\u00fargica del tromboembolisme ven\u00f3s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-28T15:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"L&#8217;actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica\",\"datePublished\":\"2013-10-28T15:01:41+00:00\",\"dateModified\":\"2013-10-28T15:01:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/\"},\"wordCount\":129,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg\",\"keywords\":[\"Publicacions\"],\"articleSection\":[\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/\",\"name\":\"L'actualitzaci\u00f3 del tractament de l'hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg\",\"datePublished\":\"2013-10-28T15:01:41+00:00\",\"dateModified\":\"2013-10-28T15:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage\",\"url\":\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg\",\"contentUrl\":\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L&#8217;actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'actualitzaci\u00f3 del tractament de l'hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/","og_locale":"ca_ES","og_type":"article","og_title":"L'actualitzaci\u00f3 del tractament de l'hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Aqu\u00ed trobareu el n\u00famero de la\u00a0revista cient\u00edfica del Col\u00b7legi\u00a0Circular Farmac\u00e8utica,\u00a0corresponent al tercer trimestre de 2013. Els temes tractats s\u00f3n, entre d\u2019altres: Farmacoter\u00e0pia &#8211; Actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica &#8211; Gesti\u00f3 terap\u00e8utica i\u00a0la infecci\u00f3 f\u00fangica invasiva en el pacient adult &#8211;\u00a0Estudi de l\u2019adequaci\u00f3 de la profilaxi quir\u00fargica del tromboembolisme ven\u00f3s [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-10-28T15:01:41+00:00","og_image":[{"url":"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"L&#8217;actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica","datePublished":"2013-10-28T15:01:41+00:00","dateModified":"2013-10-28T15:01:41+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/"},"wordCount":129,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg","keywords":["Publicacions"],"articleSection":["Not\u00edcies farm\u00e0cia"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/","url":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/","name":"L'actualitzaci\u00f3 del tractament de l'hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg","datePublished":"2013-10-28T15:01:41+00:00","dateModified":"2013-10-28T15:01:41+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#primaryimage","url":"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg","contentUrl":"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/10\/Dibujo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/10\/28\/lactualitzacio-del-tractament-de-lhepatitis-cronica-un-dels-temes-del-nou-numero-de-la-circular-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"L&#8217;actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica, un dels temes del nou n\u00famero de la Circular Farmac\u00e8utica"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Aqu\u00ed trobareu el n\u00famero de la\u00a0revista cient\u00edfica del Col\u00b7legi\u00a0Circular Farmac\u00e8utica,\u00a0corresponent al tercer trimestre de 2013. Els temes tractats s\u00f3n, entre d\u2019altres: Farmacoter\u00e0pia &#8211; Actualitzaci\u00f3 del tractament de l&#8217;hepatitis cr\u00f2nica &#8211; Gesti\u00f3 terap\u00e8utica i\u00a0la infecci\u00f3 f\u00fangica invasiva en el pacient adult &#8211;\u00a0Estudi de l\u2019adequaci\u00f3 de la profilaxi quir\u00fargica del tromboembolisme ven\u00f3s [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/3902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=3902"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/3902\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=3902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=3902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=3902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}